Variation in coeliac disease serology practices may impact biopsy-free diagnosis in Australasia
Abstract
No abstract availableFunding Information
- Teva Pharmaceutical Industries
- Chugai Pharmaceutical
This publication has 7 references indexed in Scilit:
- Accuracy of the No-Biopsy Approach for the Diagnosis of Celiac Disease in Adults: A Systematic Review and Meta-AnalysisGastroenterology, 2024
- Australasian paediatric gastroenterologist practices of coeliac disease diagnosis before and during the COVID‐19 pandemicJournal of Paediatrics and Child Health, 2022
- Australasian Pediatric Gastroenterologists’ Perspectives and Practices of Celiac Disease Diagnosis and ManagementDigestive Diseases and Sciences, 2021
- Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohortsGut, 2020
- Assessment of European Society of Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) guidelines in an Australian paediatric populationPathology, 2020
- European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020Journal of Pediatric Gastroenterology and Nutrition, 2020
- Barriers to implementing the revised ESPGHAN guidelines for coeliac disease in children: a cross-sectional survey of coeliac screen reporting in laboratories in EnglandArchives of Disease in Childhood, 2017